$4.57
Today
as of Sep 4, 16:51 ET
Last 30 days
Recent Press Releases & News
MiMedx (MDXG) Q2 2026 Earnings Call Transcript
MiMedx Group, Inc. Q2 2026 Earnings Call Summary
MiMedx Group Inc (MDXG) (Q2 2026) Earnings Call Highlights: Surgical Growth and Transformative ...
Overview
52-week range
$3.03
$7.97
31% of range
Avg surprise (last 2)
+33.3%
Avg reaction (last 1)
-0.6%
0% positive
Latest IV / EM
775%
EM ±32.4% · $5 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.10 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-0.07 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.11 | — | — | — | — | financials |
| Wed Jul 30, 2025 | Jun/2025 | $0.10 | $0.06 | +66.7% | — | — | earnings |
| Wed Apr 30, 2025 | Mar/2025 | $0.06 | $0.06 | 0.0% | — | -0.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.05 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.12 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.06 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.06 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.01 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.06 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $64M | $59M | — | $114M | $99M | $88M | — | $84M |
| Cost of revenue | $20M | $17M | — | $19M | $19M | $17M | — | $15M |
| Gross profit | $44M | $42M | — | $95M | $80M | $72M | — | $69M |
| Operating income | $-18M | $-16M | — | $22M | $12M | $8M | — | $11M |
| Net income | $-15M | $-11M | — | $17M | $10M | $7M | — | $8M |
| EPS (diluted) | $-0.10 | $-0.07 | — | $0.11 | $0.06 | $0.05 | — | $0.05 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $136M | $160M | $166M | $142M | $119M | $106M | $104M | $89M |
| Inventory | $21M | $26M | $25M | $27M | $25M | $24M | $24M | $24M |
| Total current assets | $205M | $240M | $277M | $254M | $221M | $200M | $192M | $172M |
| Total assets | $281M | $309M | $343M | $319M | $291M | $270M | $264M | $244M |
| Long-term debt | $16M | $16M | $16M | $17M | $17M | $18M | $18M | $18M |
| Total liabilities | $65M | $66M | $86M | $80M | $74M | $68M | $71M | $63M |
| Total equity | $216M | $243M | $257M | $239M | $217M | $203M | $193M | $181M |